Ask AI
ProCE Banner Activity

Expert Insights in PAH Care: Answers to Your Frequently Asked Questions

Clinical Thought

Learn how to differentiate the pathophysiologic pathways of pulmonary arterial hypertension (PAH), understand the latest data on new and emerging therapies, and gain strategies to leverage advanced practice providers to optimize PAH care, through an expert-written ClinicalThought commentary, downloadable slides, and on-demand webcasts.

Released: December 26, 2025

Continue Activity View Activity

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with the the Academy of Physician Associates in Cardiology (APAC).

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Partners

Academy of Physician Associates in Cardiology (APAC)

ProCE Banner

Target Audience

This activity is intended for cardiology-focused nurse practitioners, physician associates, clinical nurse specialists, and advanced degree nurses. ANCC and AAPA accreditation will be offered.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Differentiate key pathophysiologic pathways involved in PAH, including right heart structure and function, and their implications for diagnostic strategies

  • Evaluate the latest clinical safety and efficacy data for new and emerging PAH therapies to personalize treatment plans

  • Assess patient response to treatment and determine when to escalate therapy, including the integration of combination therapy, to optimize treatment goals

  • Leverage the unique role of an APP to bring quality of life, mental health, and shared decision-making into clinical practice to optimize patient treatment adherence and efficacy

Disclosure

Primary Author

Brian P. Rose, PA-C, MPH, AACC: consultant/advisor/speaker: Bayer, Johnson & Johnson, Lexicon, scPharmaceuticals.